Liraglutide reduces the body weight and waist circumference in Chinese overweight and obese type 2 diabetic patients

AIM: To investigate the effects of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor activator, on body weight and waist circumference in Chinese overweight and obese type 2 diabetic patients. METHODS: A total of 328 Chinese overweight and obese type 2 diabetic patients were included in this m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Acta Pharmacol Sin
Autors principals: Feng, Ping, Yu, De-min, Chen, Li-ming, Chang, Bao-cheng, Ji, Qiu-di, Li, Shu-ying, Zhu, Mei, Ding, Sheng-hua, Zhang, Bao-zhen, Wang, Su-li, Li, Hong-tao, Lin, Jing-na, Wang, Mao-jun, Guo, Jian-chao, Liu, Jie, Liu, Zhong-dong, Wu, Shen-tao, Yang, Ju-hong
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4326793/
https://ncbi.nlm.nih.gov/pubmed/25619391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2014.136
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars